News & Media

Directorate change

06 June 2006

Synexus Clinical Research Plc is pleased to announce the appointment of Malcolm Hughes (aged 52) as Non-Executive Director with immediate effect.

Malcolm is currently Chief Executive of Greenman Group plc (“Greenman”), a private industrial company which supplies printer cartridges to European office supplies distributors from its manufacturing base in Bulgaria. Prior to Greenman, he was Chief Executive of Oasis Healthcare Plc for four years during which Oasis grew from a small regional business to become the leading dental practice owner/operator in the UK with turnover of over £70m. His previous experience includes senior management roles at Chloride Group plc, Ladbroke Group plc and Management Consulting Group plc.

Commenting on the appointment, Michael Fort, chief executive of Synexus said :

“ I am delighted to welcome Malcolm to the Synexus board. He brings with him considerable knowledge and expertise, not only within the healthcare industry but also particular experience of business operations within the emerging economies of Eastern Europe where Synexus has established a foothold and from which we aim to expand rapidly. We look forward to benefiting from his contribution to the development and implementation of our growth strategy.”

Malcolm Hughes commented:

“I am delighted to be joining Synexus at a time when it is seeking to build on its recent AIM flotation through expansion of its operations in the UK and internationally. Its unique business model offers a strong proposition to global pharmaceutical companies as they aim to develop more cost-effective methods of trialling new drug treatments.”

Additional Information

The following is a complete list of Mr Hughes’ directorships as required under Schedule 2(g) of the AIM Rules: